Katherine Riester

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

Ralf Gold, Gavin Giovannoni, Krzysztof Selmaj et al. · The Lancet · 2013 · 285 citations

Relapsing-remitting Multiple Sclerosis, Clinical Trials, Treatment Option +7

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Ludwig Kappos, Heinz Wiendl, Krzysztof Selmaj et al. · New England Journal of Medicine · 2015 · 258 citations · Full text

Perinatal Transmission of Hepatitis C Virus from Human Immunodeficiency Virus Type 1‐Infected Mothers

David L. Thomas, Stephen Villano, Katherine Riester et al. · The Journal of Infectious Diseases · 1998 · 244 citations · Full text

Prevalence and Predictors of Squamous Cell Abnormalities in Papanicolaou Smears From Women Infected With HIV-1

L. Stewart Massad, Katherine Riester, Kathryn Anastos et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 1999 · 203 citations

Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women‚s Interagency HIV Study

Tracey E. Wilson, L. Stewart Massad, Katherine Riester et al. · AIDS · 1999 · 98 citations · Full text